Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 2008The Journal of Infectious Diseases

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAnn R. FalseyUniversity of RochesterEWEdward E. WalshUniversity of Rochester Medical CenterJCJose CapellanSanofi (Canada)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Falsey et al. (2008) studied this question.

synapsesocial.com/papers/6a0edadd2eca052da647d95bhttps://doi.org/10.1086/592168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk Factors for Severe Respiratory Syncytial Virus Infection in Elderly Persons2004 · 244 citations
  2. 2Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults1999 · 49 citations